We believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
For providers
Education, solutions & support
Our market-leading GPOs connect physicians and manufacturers for unrivaled purchasing power and education while our provider solutions offer tailored services for all sites of care. Plus, field reimbursement support helps practices navigate payment for these new products.
Our relationships span:
Nearly
100%
of U.S. hospitals and health systems
Oncology
60%
of U.S. community oncology market
Nephrology
90%
of U.S. renal market
Rheumatology
2,100
provider sites
Ophthalmology
4,200
provider sites
Download the white paper
The landscape of available biosimilars
In this white paper, we delve into the concept of biosimilars, their distinctions from generics, their impact on reimbursement policies, and the challenges and opportunities they present to healthcare providers, payers, and manufacturers.
